4 million doses of Pfizer, Moderna likely through COVAX by August

Indemnity issue to be settled to bring the two US vaccines through COVAX

Moderna
All doses delivered through COVAX are covered by its no-fault compensation programme
Sohini Das Mumbai
2 min read Last Updated : Jul 07 2021 | 11:17 PM IST
The global Covid vaccine collaboration COVAX says all participants in the facility must have signed the indemnity agreements with the manufacturers in question to receive doses through COVAX.

Before the Moderna and Pfizer messenger ribonucleic acid (or mRNA) vaccines come to India via this route, the legalities around the indemnity clause will have to be settled.

India is expecting 3-4 million doses of Covid vaccines from US majors Moderna and Pfizer soon, claimed Reu­ters. The international agency said around 3-4 million shots are expected in India through the COVAX facility in August.

COVAX, led by the Gavi vaccine alliance and the World Health Organization, is likely to ship US-made vaccine doses to India as early as this month.

Senior government officials, too, confirmed that procuring vaccine doses through COVAX is an option being actively considered. “Bringing Pfizer and Moderna vaccines through COVAX is one of the routes under consideration,” reiterated an official.

All doses delivered through COVAX are covered by its no-fault compensation programme.

A spokesperson for Gavi told Business Standard, “All facility participants must have signed the indemnity agreements with the manufacturers to receive doses through COVAX — this will also be true for doses received via bilateral deals.”


The facility is helping facilitate the process of getting these agreements in place for lower-income economies, as required. “All doses delivered through COVAX to advance market commitment-eligible economies, donated or procured, are covered by the COVAX no-fault compensation scheme,” the spokesperson added.

Pfizer and Moderna had sought indemnity from legal liabilities for adverse events after vaccination. India has been discussing the issue with the two vaccine makers.

The Indian government is reviewing the legal provisions related to vaccine donations from global suppliers. Moderna vaccines have, however, already reached Pakistan and Bangladesh.

US President Joe Biden had annou­nced earlier that the US would share 80 million doses of its vaccines with the world. Apart from COVAX, the government last month cleared the way for importing Covid vaccines approved by international regulators, without bridging clinical studies. The vaccines will be made available through a tie-up with Mumbai-headquartered Cipla.

Cipla is supporting Moderna with regulatory approval for importing the vaccine to be donated to India, a company spokesperson had said. “At this stage, there is no definitive agreement on commercial supplies,” the spokesperson added. There are no updates on this, Cipla said on Wednesday.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirus VaccinePfizerVaccination

Next Story